A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma
Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This is a phase 1 study to evaluate the safety and determine maximum tolerated dose, safety &
tolerability of noscapine HCl in patients with advanced multiple myeloma